Evaluation of the Immunoprotective Effects of IF-2 GTPase and SSU05-1022 As a Candidate for a Streptococcus Suis Subunit Vaccine

Tumei Chen,Chenchen Wang,Linlin Hu,Hao Lu,Fangyu Song,Anding Zhang,Xiangru Wang,Huanchun Chen,Chen Tan
DOI: https://doi.org/10.2217/fmb-2020-0232
2021-01-01
Future Microbiology
Abstract:Aim: This study aims to develop a subunit vaccine with high cross-protection for Streptococcus suis. Materials & methods: Four-week-old female BALB/c mice were first immunized with a single and mixed protein. Various indicators, such as antibody titers and various cytokine levels, were further analyzed. Results: The results showed that purified recombinant proteins IF-2 and 1022 had a good protective effect against lethal doses of S. suis serotype 2 and S. suis serotype 9. This study showed immunization with recombinant proteins. Conclusion: IF-2 and 1022 can enhance cross-protection against S. suis serotypes 2 and 9.
What problem does this paper attempt to address?